Health X Platform Limited Q3 FY26 results deck summary

Results deck of 6 Feb 2026, summarised by AI from the filing.

Q3 FY26 revenue ₹341.3 cr (+22.0% YOY) and PAT ₹0.4 cr, with management targeting 30%+ growth CAGR over the next 5 years.

Key takeaways

1. Growth target Management targets 30%+ growth CAGR over the next 5 years
2. Flipkart transition Flipkart partnership ended; company moved from 25% minority stake back to 100% ownership of SastaSundar platform
3. Negative EBITDA EBITDA was ₹(14.8) cr in Q3 FY26 and ₹(44.6) cr in 9M FY26

Original filing on BSE

Health X Platform Limited Q1 FY27 results

As filed: Revenue ₹447 cr, EBITDA −₹8.4 cr, PAT ₹2.0 cr, EBITDA margin -1.9%.

Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹447 cr). Scored once a year-earlier consolidated quarter exists.

Earlier results and the share price after them

• Q4 FY26: Revenue ₹374 cr, EBITDA −₹25.2 cr, PAT −₹13.0 cr, EBITDA margin -6.7%. Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹374 cr). Scored once a year-earlier consolidated quarter exists. Share price after the results: +3.6% in 30 days (Nifty 500: +1.5%).

Past price moves after results do not indicate future moves. Not a recommendation.

Health X Platform Limited earnings call, investor presentation and press release summaries

• Q1 FY27: Earnings call (11 Aug 2026), Results deck (7 Aug 2026)
• Q4 FY26: Earnings call (12 Jun 2026), Results deck (1 Jun 2026)
• Q3 FY26: Earnings call (9 Feb 2026), Results deck (6 Feb 2026), Results deck (6 Feb 2026)
• Q2 FY26: Earnings call (17 Nov 2025), Results deck (13 Nov 2025)
• Q1 FY26: Results deck (16 Aug 2025)
• Q4 FY25: Earnings call (12 Jun 2025), Results deck (2 Jun 2025)
• Other events: Strategy deck (10 Jun 2026)